NRNP 6630 Final Exam (Version-2,Latest-2022/2023, 100 Q & A) / NRNP6630 Final Exam / NRNP 6630 Week 11 Final Exam / NRNP6630 Week 11 Final Exam: Walden University | 100% Verified

•



NRNP 6630 Final Exam




Question I1
1 Iout Iof I1 Ipoints
Mrs. IRosen Iis Ia I49-year-old Ipatient Iwho Iis Iexperiencing Ifibro-fog. IWhat Idoes Ithe IPMHNP Iprescribe Ifor IMrs.
IRosen Ito Iimprove Ithis Icondition?




Selected IAnswer: D. I
All Iof Ithe Iabove

• Question 2 I

0 Iout Iof I1 Ipoints
An Ielderly Iwoman Iwith Ia Ihistory Iof IAlzheimer’s Idisease, Icoronary Iartery Idisease, Iand Imyocardial Iinfarction
Ihad Ia Ifall Iat Ihome I3 Imonths Iago Ithat Iresulted Iin Iher Ireceiving Ian Iopen Ireduction Iinternal Ifixation. IWhile

Iassessing Ithis Ipatient, Ithe IPMHNP Iis Imade Iaware Ithat Ithe Ipatient Icontinues Ito Iexperience Imild Ito Imoderate

Ipain. IWhat Iis Ithe IPMHNP Imost Ilikely Ito Ido?



Selected IAnswer: A. I
Order Ian IX-ray Ibecause Iit Iis Ipossible Ithat Ishe Idislocated Iher Ihip.

• Question 3 I

1 Iout Iof I1 Ipoints
The IPMHNP Iis Icaring Ifor Ia Ipatient Iwho Ireports Iexcessive Iarousal Iat Inighttime. IWhat Icould Ithe IPMHNP Iuse
Ifor Ia Itime-limited Iduration Ito Ishift Ithe Ipatient’s Ibrain Ifrom Ia Ihyperactive Istate Ito Ia Isleep Istate? I I I




Selected IAnswer: B. I
Benzodiazepines

• Question 4 I

1 Iout Iof I1 Ipoints
A Ipatient Iaddicted Ito Iheroin Iis Ireceiving Itreatment Ifor Idetoxification. IHe Ibegins Ito Iexperience Itachycardia, I

tremors, Iand Idiaphoresis. IWhat Imedication Iwill Ithe IPMHNP Iprescribe Ifor Ithis Ipatient?
Selected IAnswer: D. I
Clonidine I(Catapres)

• Question 5 I

1 Iout Iof I1 Ipoints
The IPMHNP Iprescribes Igabapentin I(Neurontin) Ifor Ia Ipatient’s Ichronic Ipain. IHow Idoes Ithe IPMHNP Ianticipate
Ithe Idrug Ito Iwork?

, Selected IAnswer: A. I
It Iwill Ibind Ito Ithe Ialpha-2-delta Iligand Isubunit Iof Ivoltage-sensitive Icalcium Ichannels.

• Question 6 I

1 Iout Iof I1 Ipoints
A Ipatient Iwith Ihypersexual Idisorder Iis Ibeing Iassessed Ifor Ipossible Ipharmacologic Itreatment. IWhy Idoes Ithe
IPMHNP Iprescribe Ian Iantiandrogen Ifor Ithis Ipatient?




Selected IAnswer: C. I
It Iwill Iblock Itestosterone.

• Question 7 I

1 Iout Iof I1 Ipoints
Which Istatement Ibest Idescribes Ia Ipharmacological Iapproach Ito Itreating Ipatients Ifor Iimpulsive Iaggression?

Selected IAnswer: D. I
Opioid Iantagonists Ican Ibe Iused Ito Ireduce Idrive.

• Question 8 I

1 Iout Iof I1 Ipoints
A I26-year-old Ifemale Ipatient Iwith Inicotine Idependence Iand Ia Ihistory Iof Ianxiety Ipresents Iwith Isymptoms Iof
Iattention Ideficit Ihyperactivity Idisorder I(ADHD). IBased Ion Ithe Iassessment, Iwhat Idoes Ithe IPMHNP Iconsider?

Selected IAnswer: A. I
ADHD Iis Ioften Inot Ithe Ifocus Iof Itreatment Iin Iadults Iwith Icomorbid Iconditions.

• Question 9 I

1 Iout Iof I1 Ipoints
A Ipatient Iwith Iirritable Ibowel Isyndrome Ireports Ichronic Istomach Ipain. IThe IPMHNP Iwants Ito Iprescribe Ithe Ipatient Ian
Iagent Ithat Iwill Icause Iirrelevant Inociceptive Iinputs Ifrom Ithe Ipain Ito Ibe Iignored Iand Ino Ilonger Iperceived Ias

Ipainful. IWhich Idrug Iwill Ithe IPMHNP Iprescribe?

Selected IAnswer: C. I
Duloxetine I(Cymbalta)




• Question 10 I

1 Iout Iof I1 Ipoints
Parents Iof Ia I12-year-old Iboy Iwant Ito Iconsider Iattention Ideficit Ihyperactivity Idisorder I(ADHD) Imedication Ifor
Itheir Ison. IWhich Imedication Iwould Ithe IPMHNP Istart?
I

Selected IAnswer: All Iof Ithe Iabove Icould Ipotentially Itreat Itheir Ison’s Isymptoms.

• Question 11 I

1 Iout Iof I1 Ipoints
Which Iof Ithe Ifollowing Iis Ia Itrue Istatement Iregarding Ithe Iuse Iof Istimulants Ito Itreat Iattention Ideficit I

hyperactivity Idisorder I(ADHD)?
Selected B. I
Signal
IAnswer: Istrength Ioutput Iis Iincreased Iby Idialing Iup Ithe Irelease Iof Idopamine I(DA) Iand

Inorepinephrine I(NE).